knowledge -WSS

knowledge

author：fashion 2025-09-06 02:12:56 - browse：436

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — This week, European regulators are considering an appeal from Amylyx Pharmaceuticals after initially recommending against approving the company’s ALS treatment — the latest potential turning point for a drug that has seen its share of ups and downs with regulatory bodies.

In June, a European Medicines Agency committee issued a negative review of Amylyx’s drug, called Albrioza, and cast doubt on whether it had demonstrated effectiveness in its pivotal study. That would have almost certainly led to a rejection by regulators, but Amylyx requested what’s called a re-examination of the opinion. On Tuesday, the EMA held a meeting on the appeal, and a decision is expected in the coming weeks.

“There are patients who are dying and they really want access to the drug,” said Evy Reviers, the chairwoman of the European Organization for Professionals and Patients with ALS, whose father has the neurological disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Pharma budget tightening trickles down to Doximity

explore

WSS

H5N1 bird flu outbreak: Second human case reported, in Michigan

Target recalls 2.2 million additional candles due to laceration, burn hazards

TB outbreak tied to bone grafts underscores testing shortcomings

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

H5N1 bird flu outbreak: Second human case reported, in Michigan

GOP presidential candidates start declaring their loyalty

hotspot

knowledge

explore

In Memoriam: Notable people who died in 2023

Questions and answers about ramping up H5N1 bird flu vaccine

Alkermes shareholders re

Questions and answers about ramping up H5N1 bird flu vaccine

The high cost of giving birth even with insurance

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Large hospital system sues Multiplan for low

Jerome Adams on the need for new antivirals for Covid

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

hotspot

Novo acquires Inversago for up to $1 billion

Bird flu surveillance in wastewater gets boost from consortium

Maui funeral service workers on devastation of fires: 'I'm in shock'

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Digital health: a case of mistaken identity

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

explore

focus

focus

knowledge